-
Healthcare Resource Utilization And Costs Following Disease Progression With First-Line Systemic Therapy In Patients With Advanced Endometrial Cancer in the US
Mar 10, 2025, 14:00 PM -
Cost Effectiveness Analysis of Lanadelumab vs C1 Inhibitor for Long-Term Prophylaxis of Hereditary Angioedema: A Brazilian Private Sector Perspective
Mar 10, 2025, 14:00 PM -
Differences in Demographic and Clinical Profiles Among Patients Adherent Vs. Non-Adherent to Revefenacin Following a COPD-Related Hospitalization
Mar 10, 2025, 14:00 PM -
A Real-World Analysis of Patient Cost Burden From COPD and Its Treatment Regimens
Mar 10, 2025, 14:00 PM -
Budget Impact Model of Enhanced Lung Cancer Screening With AI/ML Tech-Based Software as a Medical Device (SaMD) on a US Cohort and Private Payer Perspective
Mar 10, 2025, 14:00 PM -
Use of Patient Support Program Data for Real-World Evidence Generation: Opportunities and Pitfalls Illustrated in a Case Study Assessing Trastuzumab Deruxtecan Among Patients With Breast Cancer
Mar 10, 2025, 14:00 PM -
Economic Evaluation of Detection, Treatment, and Prevention Interventions for Perinatal Mood and Anxiety Disorders: A Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Cost-Utility Analysis of Migraine Prevention Treatments for Chronic Migraine Headaches Patients in the United States
Mar 10, 2025, 14:00 PM -
Regional Differences in IVF Utilization Rates in Hungary in the Last Decade
Mar 10, 2025, 14:00 PM -
Trial-Based Economic Evaluation of 'Partner in Balance,' a Blended Self-management Program for Early-Stage Dementia Caregivers in the Netherlands: The Health-Economic Analysis Plan and Baseline Results
Mar 10, 2025, 14:00 PM -
Market Size and Dispensing Patterns for Rheumatoid Arthritis Medications in SUS (Brazil, 2019–2023)
Mar 10, 2025, 14:00 PM -
The Use of Large Language Models for Systematic Literature Review Automation: An Evaluation of Quality and Time Savings
Mar 10, 2025, 14:00 PM -
Effectiveness of Digital Care Platforms for Cancer Patients: A Systematic Review and Meta-Analysis
Mar 10, 2025, 14:00 PM -
Healthcare Resource Use in Commercially- and Medicaid-Insured Infants, Toddlers, and Children Diagnosed With Invasive Meningococcal Disease in the United States
Mar 10, 2025, 14:00 PM -
Early Germline BRCA Testing in Breast Cancer: A Review of Value Frameworks and Cost-Effectiveness Analyses
Mar 10, 2025, 14:00 PM -
Assessing Disease Severity: How HTA Bodiea Evaluate Unmet Needs and Influemce Decision-Making
Mar 10, 2025, 14:00 PM -
Real-World Effectiveness of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in Poland in Comparison With Efficacy Reported in Clinical Trials
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Lenvatinib vs Key Comparators in First-Line Unresectable Hepatocellular Carcinoma in Canada
Mar 10, 2025, 14:00 PM -
Preferences for Parkinson's Disease Treatments: A Scoping Literature Review
Mar 10, 2025, 14:00 PM -
Access and Quality of Usual Source of Care and Racial/Ethnic Disparities in US Adults with Multiple Chronic Conditions
Mar 10, 2025, 14:00 PM
